Yarema Kristin
Insider CIK 1803794 · ATRA Chief Commercial Officer · PSTX President, Cell Therapy, Director · IMA Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMA ImageneBio, Inc. | A Award deriv | 2026-08-14 | 2026-08-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2026-08-14 | 2026-08-17 | 137,200 | — | $0 | 137,200 | SEC↗ |
| IMA ImageneBio, Inc. | A Award | 2026-08-14 | 2026-08-17 | 254,800 | — | $0 | 493,705 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2026-08-14 | 2026-08-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2026-08-14 | 2026-08-17 | 137,200 | — | $0 | 137,200 | SEC↗ |
| IMA ImageneBio, Inc. | A Award | 2026-08-14 | 2026-08-17 | 254,800 | — | $0 | 493,705 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise deriv | 2026-07-25 | 2026-07-28 | 38,376 | — | $0 | 115,129 | SEC↗ |
| IMA ImageneBio, Inc. | J Other deriv | 2026-07-25 | 2026-07-28 | 115,129 | — | $0 | 0 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise | 2026-07-25 | 2026-07-28 | 38,376 | — | $0 | 123,776 | SEC↗ |
| IMA ImageneBio, Inc. | J Other | 2026-07-25 | 2026-07-28 | 115,129 | — | $0 | 238,905 | SEC↗ |
| IMA ImageneBio, Inc. | J Other deriv | 2026-07-25 | 2026-07-28 | 115,129 | — | $0 | 0 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise deriv | 2026-07-25 | 2026-07-28 | 38,376 | — | $0 | 115,129 | SEC↗ |
| IMA ImageneBio, Inc. | J Other | 2026-07-25 | 2026-07-28 | 115,129 | — | $0 | 238,905 | SEC↗ |
| IMA ImageneBio, Inc. | M Exercise | 2026-07-25 | 2026-07-28 | 38,376 | — | $0 | 123,776 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2026-03-16 | 2026-03-18 | 128,100 | — | $0 | 128,100 | SEC↗ |
| IMA ImageneBio, Inc. | A Award | 2026-03-16 | 2026-03-18 | 85,400 | — | $0 | 85,400 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2025-07-28 | 2025-07-30 | 460,515 | — | $0 | 460,515 | SEC↗ |
| IMA ImageneBio, Inc. | A Award deriv | 2025-07-28 | 2025-07-30 | 153,505 | — | $0 | 153,505 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 498,325 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 345,200 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 615,836 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 345,200 | — | $0 | 345,200 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-01-02 | 2024-01-04 | 250,000 | — | $0 | 606,836 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-04-11 | 2023-04-12 | 498,325 | — | $0 | 498,325 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-04-11 | 2023-04-12 | 356,836 | — | $0 | 356,836 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-03 | 85,592 | — | $0 | 85,592 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-03-01 | 2022-03-03 | 45,533 | — | $0 | 171,415 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2021-06-14 | 2021-06-15 | 3,500 | $14.48 | $50.7K | 97,049 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2021-06-14 | 2021-06-15 | 28,833 | $14.58 | $420.4K | 125,882 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2021-06-11 | 2021-06-15 | 2,021 | $14.50 | $29.3K | 93,549 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2021-05-18 | 2021-05-20 | 761 | $14.55 | $11.1K | 91,528 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-03-01 | 2021-03-03 | 52,862 | — | $0 | 52,862 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-03-01 | 2021-03-03 | 35,021 | — | $0 | 92,289 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-03-01 | 2020-03-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-02-18 | 2020-02-19 | 110,000 | — | $0 | 110,000 | SEC↗ |